Contact Careers rss
News about the Enterprise's Stakeholders.

AVAC Announces New Web Site For Comprehensive Coverage of Biomedical HIV Prevention Research

Visit the new AVAC web site: The site contains AVAC’s comprehensive coverage of the full range of biomedical HIV prevention interventions in an easy-to-use format that is searchable by intervention and by topic like policy, ethics and community involvement in research.

Collaboration for AIDS Vaccine Discovery Recognizes Adel Benlahrech and Yufei Wang for their Contributions to HIV Vaccine Research

To support the Global HIV Vaccine Enterprise’s efforts to raise the visibility and participation in the HIV vaccine field of Young and Early Career Investigators, the CAVD recognizes the young or early career investigators who have made significant contributions to research conducted within the CAVD. For more information, please click here.

Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate

The International AIDS Vaccine Initiative (IAVI) announced today that it has signed a memorandum of understanding with the Ragon Institute to accelerate the development of new and promising AIDS vaccine candidates for testing

Wellcome Trust and Merck Launch First of its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries

MSD Wellcome Trust Hilleman Laboratories is a first of its kind research and development joint venture with a not-for-profit mission focusing on developing affordable vaccines to prevent diseases that commonly affect low-income countries. For more information, please see the press release below.

Two New Antibodies Found to Cripple HIV

Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram Biosciences have discovered two powerful new antibodies to HIV that reveal what may be an Achilles heel on the virus.

Syndicate content
Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2009 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account